ロード中...
Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
INTRODUCTION: Sub-dermal hormone implants, such as levonorgestrel (LNG), are a safe and desirable form of long-acting contraception, but their use among HIV-positive women on antiretroviral therapy (ART) may be compromised given the potential for a cytochrome P450 3A-mediated drug–drug interaction....
保存先:
| 出版年: | J Int AIDS Soc |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International AIDS Society
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224805/ https://ncbi.nlm.nih.gov/pubmed/25393993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19484 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|